Drugs / COVID-19 Vaccine AstraZeneca
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04760132 Comparator | Feb 2021 → Dec 2023 | Orthocoronavirinae infectious disease | Jens D Lundgren, MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID-19 Vaccine AstraZeneca | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04760132 ↗ |
| Modality | Vaccine | “COVID-19 Vaccine AstraZeneca suspension for injection” NCT04760132 ↗ |